Transarterial Chemoembolization Combined With PD-1 Inhibitors Plus Lenvatinib Showed Improved Efficacy for Treatment of Unresectable Hepatocellular Carcinoma Compared With PD-1 Inhibitors Plus Lenvatinib

Background: Programmed cell death protein-1 inhibitors combined with lenvatinib have become a popular treatment option for patients with unresectable hepatocellular carcinoma. Transarterial chemoembolization combined with programmed cell death protein-1 inhibitors and lenvatinib has also shown preli...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jinfeng, Zhao, Man, Han, Guangjie, Han, Xin, Shi, Jianfei, Mi, Lili, Li, Ning, Yin, Xiaolei, Duan, Xiaoling, Hou, Jiaojiao, Yin, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Advances in Multimodal Treatment Strategies for Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185979/
https://www.ncbi.nlm.nih.gov/pubmed/37161343
http://dx.doi.org/10.1177/15330338231166765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185979/
https://www.ncbi.nlm.nih.gov/pubmed/37161343
http://dx.doi.org/10.1177/15330338231166765

Ejemplares similares